Viewing nowCombinationNewcoposizone 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
SaeHan Pharmaceutical Co., Ltd.

MFDS item code 202000769 · Approved 2020.02.10 · Insurance code 651300940
Improvement in blood pressure control for essential hypertension
This medicine can be effectively used to manage blood pressure for patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy of amlodipine or valsartan.
The recommended dose of this medicine is one tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). Dosages available are 5/80 mg, 5/160 mg, and 10/160 mg, and if blood pressure is not adequately controlled, a switch to this medication may be considered after monotherapy with individual components. In patients with renal impairment, mild and moderate (creatinine clearance greater than 10 mL/min) do not require dose adjustment, but patients with severe renal impairment (creatinine clearance less than 10 mL/min) and dialysis patients should not be prescribed this medication.
The safety and efficacy for pediatric patients under 18 years have not been established, so the administration of this medication is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimester of pregnancy, so it's important to stop taking it immediately if pregnancy is confirmed. Patients with allergies to any components of this medicine, pregnant or nursing women, patients with severe kidney or liver disease, and those with certain heart conditions should not take this medicine. Patients with low sodium or fluid levels in their body may be at risk for low blood pressure, so it's crucial to check their condition carefully before taking this medication and to monitor blood pressure closely while taking it. Patients with high potassium levels or those using medications that can increase potassium should have their blood potassium levels frequently tested. Patients with impaired kidney function or kidney transplant recipients should use this medication cautiously as it may worsen kidney function. If symptoms of angioedema, such as swelling of the face, lips, or tongue occur while taking this medicine, it should be stopped immediately and medical advice should be sought. Patients with heart failure or myocardial infarction should monitor kidney function and blood pressure closely while taking this medicine, and those with acute myocardial infarction should observe symptoms carefully during the initial period of taking this medication. Patients with reduced liver function should have their dosage limited, and any signs of liver dysfunction should be reported to healthcare providers. Dizziness or fatigue may occur while taking this medicine, so caution is needed when driving or operating machinery. When taking other medications, there may be changes in effectiveness or increased risk of side effects due to interactions, so patients must inform their healthcare providers of all medications they are taking. Women who are pregnant or planning to become pregnant should not use this medicine, and nursing mothers are also advised to avoid it as much as possible. The safety and efficacy of this medicine have not been sufficiently established for children under 18 years of age; therefore, its use is not recommended. The elderly can take similar doses as general adults, but should follow the guidance of healthcare providers based on their condition. In case of overdose, severe low blood pressure or heart problems may occur, so immediate medical attention should be sought for appropriate treatment.
Urticaria, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory difficulties accompanied by cough and fever, yellowing of skin or eyes, extreme lethargy, sudden and very severe headache, lightning headache, seizures, confusion, visual disturbances, paralysis, markedly reduced urine output
Not everyone experiences these, and they can vary from person to person.
This medicine may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, to maintain the efficacy of the drug, it should be stored at room temperature, between 1 to 30 degrees Celsius.
Dark yellow rectangular film-coated tablets
For domestic use - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
SaeHan Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.